Sex: M
Vaccine: COVID19, FLU3, FLUX, PPV, VARZOS, COVID19, FLU3, FLUX, PPV, VARZOS
Symptoms: Gait disturbance, Guillain-Barre syndrome, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Symptoms were like Guillain-Barre syndrome; Difficulty walking, needed about 3 people to help to walk; Chills; Fever (101.7f); Nausea; Unstable (feeling abnormal); Energy and strength have not been fully regained; Sore arm; This case was reported by a consumer via other manufacturer and described the occurrence of guillain barre syndrome in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis, COVID-19 VACCINE for prophylaxis, INFLUENZA VACCINE INACT (FLUZONE (FLU SHOT)) for prophylaxis and PNEUMOCOCCAL VACCINE POLYSACCHARIDE 23 VALENT (PNEUMOVAX) for prophylaxis.   Previously administered products included Covid shot with an associated reaction of pain in extremity (the patient received covid shots (1st and 2nd dose ) but not major reaction other than sore arm), Fluzone with an associated reaction of gait disturbance (The reporter also mentioned that the patient had similar reaction when he received Fluzone about year ago) and Pneumovax with an associated reaction of gait disturbance (The reporter also mentioned that the patient had similar reaction when he received Pneumovax about year ago). Concomitant products included INFLUENZA VACCINE (INFLUENZA SHOT).   On 28th October 2021, the patient received Shingrix (intramuscular). On an unknown date, the patient received Influenza vaccine (intramuscular), COVID-19 VACCINE, FLUZONE (FLU SHOT) (intramuscular) and PNEUMOVAX. On 29th October 2021, 1 days after receiving Shingrix and unknown after receiving Influenza vaccine, the patient experienced guillain barre syndrome (serious criteria hospitalization and manufacturer medically significant), walking difficulty (serious criteria hospitalization), chills (serious criteria hospitalization), fever (serious criteria hospitalization), nausea (serious criteria hospitalization), feeling abnormal (serious criteria hospitalization), asthenia (serious criteria hospitalization) and pain in arm (serious criteria hospitalization). On an unknown date, the outcome of the guillain barre syndrome and asthenia were not recovered/not resolved and the outcome of the walking difficulty, chills, fever, nausea and feeling abnormal were recovered/resolved and the outcome of the pain in arm was unknown.   The reporter considered the guillain barre syndrome, walking difficulty, chills, fever, nausea, feeling abnormal, asthenia and pain in arm to be related to Shingrix and Influenza vaccine.   Additional Information: manufacturer Receipt Date: 18-AUG-2022 Reporter's Comments: The patient who experienced chills, fever (101.7 degree F), nausea, unstable (feeling abnormal), difficulty walking, the patient need about 3 people to help him walk ,energy and strength have not been fully regained, sore arm while receiving vaccine covid-19 vaccine, Shingrix, Pnuemovax, Influenza vaccine and influenza vaccine trival A-B subvirion no preservative vaccine (Fluzone). The reporter reported that on an unknown date patient received influenza trival A-B subvirion no preservative vaccine (Fluzone) via intramuscular route in the left deltoid and lot number not provided, also received Influenza vaccine, Covid-19 vaccine and Pneumovax. The patient received Shingrix via intramuscular route. The patient past medical history, medical treatment, vaccination and family history were not provided. The reporter reported that on an unknown date patient received influenza trival A-B subvirion no preservative vaccine (Fluzone) via intramuscular route in the left deltoid and lot number not provided, also received Influenza vaccine, Covid-19 vaccine and Pneumovax. The reporter reported that on 29th October 2021, patient developed chills, fever(pyrexia), nausea, unstable (feeling abnormal), difficulty walking, energy and strength have not been fully regained, sore arm. The patient needs about 3 people to help him walk. This event was leading to disability. The patient was hospitalized around 4:00pm on the same day for all the events. The patient was discharged from emergency room around 9:30pm on 29th October 2021. It was reported Guillain- Barre syndrome (GBS) had not been diagnosed, but the reporter thinks that symptoms were like GBS. The reporter also mentioned that the patient had similar reaction when he received Fluzone and Pneumovax about year ago. The patient also mentioned that, the patient received flu shot 2 weeks prior to Shingrix vaccine but no adverse reaction. It was unknown if reporter considered the guillain barre syndrome, walking difficulty, chills, fever, nausea, feeling abnormal, asthenia and pain in arm to be related to covid-19 vaccine, Pnuemovax, Influenza vaccine and influenza vaccine trival A-B subvirion no preservative vaccine (fluzone).